The impact of CYP19A1 variants and haplotypes on breast cancer risk, clinicopathological features and prognosis.

ABSTRACT:

Background

Different genetic variants in hormone-regulating pathways have been identified to influence the risk of breast cancer. This study aimed to evaluate the association of CYP19A1 rs10046 and rs700519 polymorphisms with the risk, clinicopathological factors and prognosis of breast cancer.

Methods

In a case-control study, rs10046 and rs700519 polymorphisms were genotyped using ARMS-PCR and high-resolution melting (HRM), respectively, in a total of 702 females. Statistical analysis and evaluation of haplotypes and linkage disequilibrium were performed using SPSS v16, PHASE and 2LD.

Results

Although no association of rs700519 with breast cancer was observed, rs10046 in different genetic models as well as C-C/C-T and C-C/C-C diplotypes, revealed the association with

SUBMITTER: Alwan AM 

PROVIDER: S-EPMC8372086 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature